Thryv Therapeutics Inc. Alternatives & Competitors
12 companies similar to Thryv Therapeutics Inc. — We will relentlessly pursue our platform of kinase inhibitors, enabling people t...
Companies similar to Thryv Therapeutics Inc.
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Phoenix Molecular Designs
A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...
San Diego, United States
AlloMek Therapeutics LLC
Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Track all Thryv Therapeutics Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Certa Therapeutics
Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, United States
FibroGen, Inc.
Committed to being a place where our people and science thrive.
San Francisco, United Sta...
PanTher Therapeutics
A Quantum Leap Forward in the Fight Against Cancer
Austin, United States
Senex Biotechnology. Inc.
Preventing Adaptive Drug Resistance and Cancer Metastasis
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
Tyrogenex
Innovative biotech solutions for solid tumors through advanced multi-kinase angiogenesis i...
Strike Pharma AB
Harnessing personalized medicine to target tumors and protect healthy cells, delivering co...
About Thryv Therapeutics Inc.
Thryv Therapeutics Inc. is a Montreal-based biotechnology startup founded in 2019, previously known as LQT Therapeutics Inc. The company's focus is on developing precision medicine solutions for genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers.
Precision Medicine, Kinase Inhibitors, Genetic Diseases, Long QT Syndrome, Atrial Fibrillation, Cancer Treatment, Drug-Induced Diseases, Therapeutics, Serum Glucocorticoid Inducible Kinase, Montreal, Quebec, Canada
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Thryv Therapeutics Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Thryv Therapeutics Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
